Geode Capital Management, LLC Next Cure, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Next Cure, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 223,741 shares of NXTC stock, worth $217,028. This represents 0.0% of its overall portfolio holdings.

Number of Shares

223,741

Previous 195,929 14.19%

Holding current value

$217,028

Previous $311,000 1.61%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.33 - $1.78 $36,989 - $49,505	27,812 Added 14.19%	223,741 $306,000
Q2 2024 Aug 09, 2024	BUY	$1.17 - $2.49 $24,829 - $52,842	21,222 Added 12.15%	195,929 $311,000
Q3 2023 Nov 13, 2023	BUY	$1.29 - $1.84 $22,091 - $31,510	17,125 Added 10.87%	174,707 $225,000
Q2 2023 Aug 11, 2023	SELL	$1.47 - $1.86 $16,053 - $20,313	-10,921 Reduced 6.48%	157,582 $283,000
Q4 2022 Feb 13, 2023	SELL	$1.2 - $3.07 $394 - $1,010	-329 Reduced 0.19%	168,503 $237,000
Q3 2022 Nov 14, 2022	SELL	$2.72 - $5.19 $5,916 - $11,288	-2,175 Reduced 1.27%	168,832 $464,000
Q2 2022 Aug 12, 2022	BUY	$3.38 - $5.27 $64,882 - $101,162	19,196 Added 12.64%	171,007 $803,000
Q1 2022 May 13, 2022	BUY	$4.76 - $6.24 $41,902 - $54,930	8,803 Added 6.16%	151,811 $737,000
Q4 2021 Feb 11, 2022	BUY	$5.7 - $9.1 $13,959 - $22,285	2,449 Added 1.74%	143,008 $858,000
Q3 2021 Nov 12, 2021	BUY	$6.74 - $8.02 $35,310 - $42,016	5,239 Added 3.87%	140,559 $947,000
Q2 2021 Aug 13, 2021	SELL	$7.6 - $10.28 $874,106 - $1.18 Million	-115,014 Reduced 45.94%	135,320 $1.09 Million
Q1 2021 May 12, 2021	BUY	$9.81 - $13.88 $623,180 - $881,727	63,525 Added 34.01%	250,334 $2.51 Million
Q4 2020 Feb 12, 2021	SELL	$9.47 - $12.43 $137,599 - $180,607	-14,530 Reduced 7.22%	186,809 $2.04 Million
Q3 2020 Nov 13, 2020	SELL	$8.15 - $21.17 $26,878 - $69,818	-3,298 Reduced 1.61%	201,339 $1.77 Million
Q2 2020 Aug 13, 2020	BUY	$21.19 - $40.2 $453,148 - $859,677	21,385 Added 11.67%	204,637 $4.39 Million
Q1 2020 May 14, 2020	BUY	$32.32 - $58.37 $639,257 - $1.15 Million	19,779 Added 12.1%	183,252 $6.79 Million
Q4 2019 Feb 13, 2020	BUY	$25.0 - $92.22 $2.58 Million - $9.53 Million	103,308 Added 171.71%	163,473 $9.21 Million
Q3 2019 Nov 12, 2019	SELL	$15.73 - $41.6 $83,195 - $220,022	-5,289 Reduced 8.08%	60,165 $1.86 Million
Q2 2019 Aug 14, 2019	BUY	$14.16 - $20.64 $926,828 - $1.35 Million	65,454 New	65,454 $980,000

Others Institutions Holding NXTC

# of Institutions

Shares Held

15.9M

Call Options Held

Put Options Held

View Full List

About NextCure, Inc.

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $26.9M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

More about NXTC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Next Cure, Inc. Transaction History